国新健康：2025年全年预计净亏损4.09亿元

Core Viewpoint - Guoxin Health has released its performance forecast for 2025, expecting a significant decline in net profit attributed to shareholders, projecting a loss of 409.22 million yuan, which represents a year-on-year decrease of 3841.71% [1] Financial Performance - The company anticipates a net profit of -147.88 million yuan after deducting non-recurring gains and losses, reflecting a year-on-year decrease of 2.51% [1] - For the reporting period, the company achieved an operating revenue of approximately 351 million yuan, remaining stable compared to the previous year [1] - The net profit attributable to shareholders is projected to be around -409.22 million yuan, indicating a significant increase in losses [1] Reasons for Performance Changes - The primary reason for the performance decline is the expected impairment of trading financial assets, specifically a 99.01% partnership interest in Shenzhou Borui (Shenzhen) Investment Enterprise [1] - The decline in operating performance of Shenzhou Medical Technology Co., Ltd., in which Shenzhou Borui holds a 7.66% stake, is expected to lead to a fair value loss of approximately 260 million yuan on the company's trading financial assets [1] Strategic Focus - The company is aligning its strategies with the "Healthy China" initiative and the "Three Medical Coordination" reform, focusing on health data integration, management services, and innovative health services [1] - The strategic direction emphasizes digital transformation and the value extraction of health data to support the national strategy for "Healthy China" [1]